Metabolic Syndrome and Uric Acid Nephrolithiasis

Seminars in Nephrology

Volumn 28, Issue 2, 2008, Pages 174-180

  Sakhaee, Khashayar ^a   Maalouf, Naim M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

insulin resistance; metabolic syndrome; Uric acid nephrolithiasis; urine ammonium; urine pH

Indexed keywords

AMMONIA; GLYCOSAMINOGLYCAN; INSULIN; URIC ACID;

ACIDURIA; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BODY MASS; CHEMICAL REACTION; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; NEPHROLITHIASIS; NEPHROTOXICITY; NEUROARTHRITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; URIC ACID STONE; URINARY EXCRETION; URINE PH;

HUMANS; HYDROGEN-ION CONCENTRATION; METABOLIC SYNDROME X; NEPHROLITHIASIS; URIC ACID;

EID: 40849118155     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2008.01.010     Document Type: Article

References (63)

1. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
2. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
3. Reaven G.M. The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis 30 (1997) 928-931
4. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
5. Stamatelou K.K., Francis M.E., Jones C.A., et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63 (2003) 1817-1823
6. Yoshida O., Terai A., Ohkawa T., et al. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56 (1999) 1899-1904
7. Serio A., and Fraioli A. Epidemiology of nephrolithiasis. Nephron 81 Suppl 1 (1999) 26-30
8. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
9. Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg 13 (2003) 329-330
10. Taylor E.N., Stampfer M.J., and Curhan G.C. Obesity, weight gain, and the risk of kidney stones. JAMA 293 (2005) 455-462
11. Taylor E.N., Stampfer M.J., and Curhan G.C. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68 (2005) 1230-1235
12. Atsmon A., DeVries A., and Frank M. Uric acid lithiasis (1963), Elsevier, Amsterdam
13. Hossain R.Z., Ogawa Y., Hokama S., et al. Urolithiasis in Okinawa, Japan: a relatively high prevalence of uric acid stones. Int J Urol 10 (2003) 411-415
14. Hesse A., Schneider H.J., Berg W., et al. Uric acid dihydrate as urinary calculus component. Invest Urol 12 (1975) 405-409
15. Mandel N.S., and Mandel G.S. Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J Urol 142 (1989) 1516-1521
16. Ekeruo W.O., Tan Y.H., Young M.D., et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 172 (2004) 159-163
17. Daudon M., Lacour B., and Jungers P. Influence of body size on urinary stone composition in men and women. Urol Res 34 (2006) 193-199
18. Pak C.Y., Sakhaee K., Moe O., et al. Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61 (2003) 523-527
19. Daudon M., Lacour B., and Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 20 (2005) 468-469
20. Daudon M., Traxer O., Conort P., et al. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17 (2006) 2026-2033
21. Rafey M.A., Lipkowitz M.S., Leal-Pinto E., et al. Uric acid transport. Curr Opin Nephrol Hypertens 12 (2003) 511-516
22. Asplin J.R. Uric acid stones. Semin Nephrol 16 (1996) 412-424
23. Finlayson B., and Smith L. Stability of first dissociable proton of uric acid. J Chem Engl Data 19 (1974) 94-97
24. Pak C.Y., and Arnold L.H. Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med 149 (1975) 930-932
25. Pak C.Y., Hayashi Y., and Arnold L.H. Heterogeneous nucleation with urate, calcium phosphate and calcium oxalate. Proc Soc Exp Biol Med 153 (1976) 83-87
26. Pak C.Y., Waters O., Arnold L., et al. Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate. J Clin Invest 59 (1977) 426-431
27. Coe F.L., and Kavalach A.G. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 291 (1974) 1344-1350
28. Wilcox W.R., Khalaf A., Weinberger A., et al. Solubility of uric acid and monosodium urate. Med Biol Eng 10 (1972) 522-531
29. Sakhaee K., Nicar M., Hill K., et al. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int 24 (1983) 348-352
30. Riese R.J., and Sakhaee K. Uric acid nephrolithiasis: pathogenesis and treatment. J Urol 148 (1992) 765-771
31. Maalouf N.M., Cameron M.A., Moe O.W., et al. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13 (2004) 181-189
32. Pak C.Y. Uric acid nephrolithiasis. In: Resnick M.I., and Pak C.Y. (Eds). Urolithiasis, a medical and surgical reference (1990), WB Saunders, Philadelphia 105-112
33. Pak C.Y. Medical management of nephrolithiasis in Dallas: update 1987. J Urol 140 (1988) 461-467
34. Moe O.W., Abate N., and Sakhaee K. Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am 31 (2002) 895-914
35. Mineo I., Kono N., Hara N., et al. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII. N Engl J Med 317 (1987) 75-80
36. Grossman M.S., and Nugent F.W. Urolithiasis as a complication of chronic diarrheal disease. Am J Dig Dis 12 (1967) 491-498
37. Sakhaee K., Nigam S., Snell P., et al. Assessment of the pathogenetic role of physical exercise in renal stone formation. J Clin Endocrinol Metab 65 (1987) 974-979
38. Reddy S.T., Wang C.Y., Sakhaee K., et al. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40 (2002) 265-274
39. Sakhaee K., Adams-Huet B., Moe O.W., et al. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 62 (2002) 971-979
40. Maalouf N.M., Sakhaee K., Parks J.H., et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65 (2004) 1422-1425
41. Cameron M.A., Maalouf N.M., Adams-Huet B., et al. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17 (2006) 1422-1428
42. DuBose Jr. T.D., Good D.W., Hamm L.L., et al. Ammonium transport in the kidney: new physiological concepts and their clinical implications. J Am Soc Nephrol 1 (1991) 1193-1203
43. Maalouf N.M., Cameron M.A., Moe O.W., et al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2 (2007) 883-888
44. Field A.E., Coakley E.H., Must A., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161 (2001) 1581-1586
45. Abate N., Chandalia M., Cabo-Chan Jr. A.V., et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65 (2004) 386-392
46. Meezan E., and Freychet P. Specific insulin receptors in rat renal glomeruli. Ren Physiol 3 (1980) 72-78
47. Nakamura R., Emmanouel D.S., and Katz A.I. Insulin binding sites in various segments of the rabbit nephron. J Clin Invest 72 (1983) 388-392
48. Krivosikova Z., Spustova V., and Dzurik R. Participation of P-dependent and P-independent glutaminases in rat kidney ammoniagenesis and their modulation by metabolic acidosis, hippurate and insulin. Physiol Res 47 (1998) 177-183
49. Chobanian M.C., and Hammerman M.R. Insulin stimulates ammoniagenesis in canine renal proximal tubular segments. Am J Physiol 253 (1987) F1171-F1177
50. Klisic J., Hu M.C., Nief V., et al. Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol 283 (2002) F532-F539
51. Fuster D.G., Bobulescu I.A., Zhang J., et al. Characterization of the regulation of renal Na+/H+ exchanger NHE3 by insulin. Am J Physiol 292 (2007) F577-F585
52. Nagami G.T. Luminal secretion of ammonia in the mouse proximal tubule perfused in vitro. J Clin Invest 81 (1988) 159-164
53. Vinay P., Lemieux G., Cartier P., et al. Effect of fatty acids on renal ammoniagenesis in in vivo and in vitro studies. Am J Physiol 231 (1976) 880-887
54. Unger R.H. Lipotoxic diseases. Annu Rev Med 53 (2002) 319-336
55. Lee Y., Hirose H., Ohneda M., et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A 91 (1994) 10878-10882
56. Szczepaniak L.S., Nurenberg P., Leonard D., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol 288 (2005) E462-E468
57. Bachmann O.P., Dahl D.B., Brechtel K., et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50 (2001) 2579-2584
58. McGavock J.M., Victor R.G., Unger R.H., et al. Adiposity of the heart, revisited. Ann Intern Med 144 (2006) 517-524
59. Szczepaniak L.S., Dobbins R.L., Metzger G.J., et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49 (2003) 417-423
60. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
61. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
62. Koka R.M., Huang E., and Lieske J.C. Adhesion of uric acid crystals to the surface of renal epithelial cells. Am J Physiol 278 (2000) F989-F998
63. Ombra M.N., Casula S., Biino G., et al. Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate. Urology 62 (2003) 416-420